Thomas Catinazzo - 27 Jan 2026 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Financial Officer
Signature
/s/ Soo-Yeun Lim, as Attorney-in-Fact
Issuer symbol
RLAY
Transactions as of
27 Jan 2026
Net transactions value
-$119,631
Form type
4
Filing time
29 Jan 2026, 16:20:25 UTC
Previous filing
15 Jan 2026
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Catinazzo Thomas Chief Financial Officer C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Soo-Yeun Lim, as Attorney-in-Fact 29 Jan 2026 0001818261

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $105,308 -13,820 -5.2% $7.62 250,996 27 Jan 2026 Direct F1, F2
transaction RLAY Common Stock Sale $14,323 -1,695 -0.68% $8.45 249,301 28 Jan 2026 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,394 shares of restricted stock units ("RSUs") on January 26, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 18,799 shares underlying RSUs.
F3 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,724 shares of RSUs on January 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F4 Includes 13,075 shares underlying RSUs.